
Cordance Medical
Non-invasive focused ultrasound system to safely open the blood-brain barrier for treating brain diseases.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Seed | |
Total Funding | 000k |
Related Content
Cordance Medical is at the forefront of medical innovation, specializing in the development of non-invasive systems using low power focused ultrasound to transiently and safely open the blood-brain barrier (BBB). This breakthrough technology addresses a critical challenge in the treatment of brain diseases and disorders, where the BBB often hinders effective drug delivery.
Cordance Medical's system is designed to be patient-friendly and widely deployable, making it accessible for a broad range of medical facilities and patients. The company operates in the medical technology market, targeting healthcare providers, hospitals, and research institutions that focus on neurological conditions.
The business model revolves around the development, manufacturing, and distribution of its ultrasound systems, generating revenue through direct sales, partnerships, and potentially licensing agreements. By enabling more effective treatments for brain diseases, Cordance Medical aims to significantly improve patient outcomes and advance the field of neurology.
Keywords: focused ultrasound, blood-brain barrier, non-invasive, brain diseases, neurological treatment, medical technology, patient-friendly, healthcare innovation, drug delivery, neurology.